Therapeutic Plasma Exchange Market Overview 2024-2033 - Share, Trends, Demand, Outlook

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Therapeutic Plasma Exchange Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $2.12 billion In 2028 At A CAGR Of 9.6% :

The therapeutic plasma exchange market size has grown strongly in recent years. It will grow from $1.35 billion in 2023 to $1.47 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to the emergence of immunological diseases, increasing technological advancements, increased awareness and education, expanded indications, and improved understanding of the pathophysiology.

The therapeutic plasma exchange market size is expected to see strong growth in the next few years. It will grow to $2.12 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to the rising geriatric population, clinical evidence and guidelines, regulatory environment, hospital infrastructure and healthcare investments, healthcare expenditure, and reimbursement policies. Major trends in the forecast period include personalized therapies, integration of automation, collaborative initiatives, and telemedicine integration.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp

Therapeutic Plasma Exchange Market Major Segments
The therapeutic plasma exchange market covered in this report is segmented -

1) By Type: Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis (DFPP)
2) By Indication: Neurological Disorders, Hematological Disorders, Renal Disorders, Metabolic Disorders, Other Indications
3) By Technology: Centrifugation, Membrane Separation
4) By End User: Blood Collection Centers, Hospitals And Clinics, Transfusion Centers, Other End Users

Key Driver - Rising Obesity Rates Fuel Growth In The Chronic Venous Occlusion Treatment Market

The high prevalence of hematological disorders is expected to propel the growth of the therapeutic plasma exchange market going forward. Hematological disorders, also known as blood disorders, refer to medical conditions that affect the blood and blood-forming tissues, including the bone marrow, lymph nodes, and spleen. Hematological disorders are rising due to factors including genetic predispositions, environmental influences, and lifestyle changes. Therapeutic plasma exchange (TPE) is utilized in hematological disorders to remove pathogenic substances from the plasma, such as autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, thereby mitigating disease severity and improving patient outcomes. For instance, in August 2023, according to the Leukemia and Lymphoma Society, a US-based professional organization, the number of projected myeloma diagnoses is expected to rise by around 2.3% from 2021 to 2023, increasing from 34,920 to 35,730, respectively. Therefore, the high prevalence of hematological disorders is driving the growth of the therapeutic plasma exchange market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=15683&type=smp

Prominent Trend - Advancements In Automated Systems For Enhanced Critical Care Delivery

Major companies operating in the therapeutic plasma exchange market are focused on developing technologically advanced products, such as automated plasma exchange systems, that can improve treatment accuracy, increase workflow efficiency, and simplify therapy setup and delivery. Automated plasma exchange systems are medical devices designed to perform therapeutic plasma exchange (TPE) procedures in a controlled and efficient manner. For instance, in May 2021, Baxter International Inc., a US-based healthcare company, launched the PrisMax 2 system, an automated plasma exchange system designed to advance critical care delivery for patients and hospitals by removing harmful substances from a patient's blood. This new system addresses key challenges faced in the intensive care unit (ICU), offering operational simplicity, smart efficiencies, and data-driven insights. The PrisMax 2 system simplifies the complexities of delivering continuous renal replacement therapy (CRRT) and other extracorporeal therapies, enhancing therapy management from setup to delivery.

Therapeutic Plasma Exchange Market Players
Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Charles River Laboratories, Octapharma AG, Spectral Medical Inc., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc., Japan Medical Supply Co. Ltd.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the therapeutic plasma exchange market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Therapeutic Plasma Exchange Market Report Structure
3. Therapeutic Plasma Exchange Market Trends And Strategies
4. Therapeutic Plasma Exchange Market - Macro Economic Scenario
5. Therapeutic Plasma Exchange Market Size And Growth
…..
27. Therapeutic Plasma Exchange Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.